메뉴 건너뛰기




Volumn 314, Issue 18, 2015, Pages 1909-1910

Predicting the overuse of PCSK-9 inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

ALIROCUMAB; ANTILIPEMIC AGENT; EVOLOCUMAB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 INHIBITOR; SUBTILISIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; PCSK9 PROTEIN, HUMAN; SERINE PROTEINASE;

EID: 84946811245     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.13414     Document Type: Note
Times cited : (8)

References (8)
  • 1
    • 84931849550 scopus 로고    scopus 로고
    • Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: A systematic review and meta-analysis
    • Navarese EP, Kolodziejczak M, Schulze V, et al. Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: A systematic review and meta-analysis. Ann Intern Med. 2015;163(1):40-51.
    • (2015) Ann Intern Med. , vol.163 , Issue.1 , pp. 40-51
    • Navarese, E.P.1    Kolodziejczak, M.2    Schulze, V.3
  • 2
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
    • Keech A, Simes RJ, Barter P, et al; FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366 (9500):1849-1861.
    • (2005) Lancet. , vol.366 , Issue.9500 , pp. 1849-1861
    • FIELD study investigators1    Keech, A.2    Simes, R.J.3    Barter, P.4
  • 3
    • 84855171302 scopus 로고    scopus 로고
    • Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy
    • Boden WE, Probstfield JL, Anderson T, et al; AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255-2267.
    • (2011) N Engl J Med. , vol.365 , Issue.24 , pp. 2255-2267
    • AIM-HIGH Investigators1    Boden, W.E.2    Probstfield, J.L.3    Anderson, T.4
  • 4
    • 84875727583 scopus 로고    scopus 로고
    • Discontinuation of statins in routine care settings: A cohort study
    • Zhang H, Plutzky J, Skentzos S, et al. Discontinuation of statins in routine care settings: A cohort study. Ann Intern Med. 2013;158(7):526-534.
    • (2013) Ann Intern Med. , vol.158 , Issue.7 , pp. 526-534
    • Zhang, H.1    Plutzky, J.2    Skentzos, S.3
  • 6
    • 84893535358 scopus 로고    scopus 로고
    • Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease
    • Montori VM, Brito JP, Ting HH. Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease. JAMA. 2014;311(5):465-466.
    • (2014) JAMA. , vol.311 , Issue.5 , pp. 465-466
    • Montori, V.M.1    Brito, J.P.2    Ting, H.H.3
  • 7
    • 84944080845 scopus 로고    scopus 로고
    • New therapies in the treatment of high cholesterol: An argument to return to goal-based lipid treatments
    • Shrank WH, Barlow JF, Brennan TA. New therapies in the treatment of high cholesterol: an argument to return to goal-based lipid treatments. JAMA. 2015;314(14):1443-1444.
    • (2015) JAMA. , vol.314 , Issue.14 , pp. 1443-1444
    • Shrank, W.H.1    Barlow, J.F.2    Brennan, T.A.3
  • 8
    • 84940594919 scopus 로고    scopus 로고
    • Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy
    • Iglay K, Cao X, Mavros P, Joshi K, Yu S, Tunceli K. Systematic literature review and meta-analysis of medication adherence with once-weekly versus once-daily therapy. Clin Ther. 2015;37(8):1813-1821.e1.
    • (2015) Clin Ther. , vol.37 , Issue.8 , pp. 1813e1-1821e1
    • Iglay, K.1    Cao, X.2    Mavros, P.3    Joshi, K.4    Yu, S.5    Tunceli, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.